Sunday, June 7, 2026

Our Life Stories Are Our Legacy- Write It!

Over the last twelve months, my blog has felt less like a collection of separate posts and more like a quiet conversation with my own life. When I look back at what I have written, I see memory, gratitude, aging, resilience, and wonder woven together into one long thread.

At this stage of life, I do not write to impress anyone. I write because writing helps me remember, and remembering helps me live. My words have become a way of honoring the years behind me while still making room for the days that remain.

Aging has been one of the most common themes in my recent reflections. I have written about it not as a defeat, but as a deeper chapter. The body changes, of course. It slows down. It asks for more patience, more care, and more acceptance. Yet age also brings its own gifts. It teaches us to value the small things: a peaceful morning, a kind word, a familiar routine, the gift of another day.

I have also written often about living alone. That is not the same as being lonely. After a long marriage and a life filled with family, work, and responsibility, solitude can carry both sorrow and grace. There are moments when silence feels heavy, yes, but there are also moments when silence becomes comforting. In those moments, I am reminded that a person can live alone and still be surrounded by love, memory, and purpose.

My blog has been a place to revisit my autobiography, my family, and the long path that brought me here. Each memory matters. Each chapter matters. When I write about the past, I am not only telling my story. I am preserving the people, places, and experiences that shaped me. Memory is a form of gratitude, and gratitude is one of the deepest truths I know.

I have also found myself returning again and again to questions that never grow old: the meaning of life, the relationship between science and faith, the mystery of the soul, and the quiet strength required to meet suffering with dignity. These are not questions with easy answers. But they are the kinds of questions that keep the heart awake.

If I have learned anything from these months of writing, it is that a life does not become less meaningful with age. In many ways, it becomes more visible. The important things stand out more clearly. Love, loss, faith, memory, endurance, and hope take on greater shape. What once seemed ordinary now feels precious.

To readers across the world, I offer this simple truth: every life contains a story worth telling. No matter how many years have passed, no matter what has been lost, there is still meaning in reflection. There is still beauty in gratitude. There is still purpose in waking up and choosing to keep going.

And so I continue to write not because I have all the answers, but because I still have memories to honor, thoughts to share, and a heart that remains open to the mystery of being alive.

This posting is a reminder that our stories are our legacy, and there is immense value in sharing, documenting, and honoring them at any stage of life. Write it!

AI Overview: Our stories are the living breath of our legacy.
They are not just memories; they are the blueprints for those who follow us. When we write them down, we transform fleeting moments into a permanent bridge across generations.

Why We Write

To Preserve Truth: If you don’t tell your story, someone else will, and they might get it wrong. Authenticity is the only way to ensure your true voice survives.
To Share Wisdom: Your triumphs, heartbreaks, and even your "silly mistakes" serve as potent lessons for your children and grandchildren.
To Anchor Identity: For many communities, storytelling is a form of survival and strength, keeping heritage alive when history books fail.

How to Start Writing Your Legacy

You don't need to write a novel to leave a mark. Small, consistent efforts often carry the most weight:

Keep "Memory Notes": Write down the small things-your first concert, how you met a partner, or what you were like at your child's current age.
Document Community History: Join initiatives like the Digital Archive projects that record oral histories to protect a neighborhood's collective memory.
Share "Heart Prints": Focus on the advice you still follow and the values you want to pass on. These are the "flames" that keep a legacy burning.

Legacy is not accidental; it is built. By choosing to write it, you ensure that your story and the stories of those who came before you-remain a gift for the future.

Finally, My Photo of the Day:

My Younger Years: FDA. 1990-2002

Saturday, June 6, 2026

Longevity: The New Luxury of the Rich

Longevity: The New Luxury of the 21st Century

Last week, I came across an article with a provocative headline: "Longevity is the New Amenity for the Rich." The article discussed a startup company called NewLimit, which has reportedly attracted hundreds of millions of dollars in investment to pursue research into aging and therapies that may extend healthy human life.

The headline stopped me in my tracks.

For most of human history, wealth was measured by land, gold, mansions, yachts, and private jets. Today, a new aspiration is emerging among the world's wealthiest individuals, not simply to live well, but to live longer.

And perhaps more importantly, to remain healthy while doing so.

As someone who has spent nearly eight decades observing medicine, science, and public health evolve, I find the growing pursuit of longevity both fascinating and deeply personal.

When I was a young man in the Philippines, average life expectancy was far lower than it is today. Diseases that once claimed millions of lives are now preventable or treatable. Vaccines, antibiotics, organ transplantation, advanced surgery, and modern diagnostics have added decades to human life.

Yet now scientists are pursuing something even more ambitious: treating aging itself.

For centuries, aging was viewed as an unavoidable fact of life. Today, researchers increasingly see aging as a biological process that may be slowed, modified, or perhaps one day partially reversed.

Companies such as NewLimit and other biotechnology firms are exploring ways to reprogram cells, repair damaged tissues, reduce inflammation, and restore youthful function at the molecular level. Artificial intelligence is accelerating the search for new drugs and therapies that once might have taken decades to discover.

The goal is not immortality.

The goal is extending what scientists call "health span"-the number of years we remain healthy, independent, and mentally sharp.

As a senior citizen myself, I understand the difference between lifespan and healthspan.

Most of us do not merely wish to add years to our lives. We hope to add life to our years.

We want to remain connected to family and friends. We want to continue learning, writing, creating, laughing, and sharing our wisdom. We want to wake up each morning with purpose.

That is the real promise of longevity science. Yet the article's headline raises an important question.

Will longevity become available only to the wealthy?

History offers reasons for both concern and optimism.

Many medical breakthroughs initially benefited only a privileged few. Over time, however, technologies often became widely accessible. Antibiotics, vaccines, computers, smartphones, and even the internet eventually reached billions of people around the world.

I hope the same will be true for future anti-aging therapies.

After all, a longer and healthier life should not be reserved for billionaires.

It should be one of humanity's shared achievements.

At the same time, I am reminded that some of the most powerful tools for healthy aging are already available to many of us.

Regular physical activity. Nutritious food. Quality sleep. Meaningful social connections.

Intellectual curiosity. A sense of purpose. Acts of kindness.

And yes, even something as simple as human touch. As many of my readers know, I have long appreciated the therapeutic value of massage and touch therapies. Science increasingly confirms that touch, companionship, and emotional connection contribute to overall well-being and quality of life.

Perhaps the greatest lesson of longevity research is that aging is not merely a biological process.

It is also a human journey. No laboratory can manufacture wisdom. No pill can create meaningful relationships.

No technology can replace love, friendship, and community.

As researchers invest billions of dollars seeking the secrets of longer life, many seniors already understand an important truth:

The value of life is measured not only by how long we live, but by how fully we live.

Whether science ultimately helps humans reach 100, 120, or even beyond, the challenge remains the same.

To use whatever time we are given with gratitude, purpose, and compassion.

That, in my view, may be the most important longevity therapy of all.

DEDICATION: The above article I dedicate to all my Senior and International Readers. It combines the latest longevity research with reflections on aging, health span, community, and the wisdom that comes with later life.

AI Overview:

Longevity has officially replaced material possession as the ultimate 21st-century status symbol. As global wealth shifts its focus from what you own to how long you thrive, a booming $610 billion longevity economy has emerged. This paradigm shift focuses heavily on healthspan- the number of years lived in vibrant, disease-free health, rather than merely extending chronological lifespan. In an era where time is the scarcest commodity, buying more high-quality time has become the apex of modern luxury. Luxury Hotel | The Estate by sbe

Longevity is the New Luxury: Is Time the Ultimate Status Symbol?

Longevity is becoming the new definition of luxury. More ...

The New Infrastructure of Healthspan

The modern longevity economy integrates advanced medical diagnostics, continuous biological tracking, and proactive intervention into premium, long-term business models.

Longevity Real Estate: Luxury real estate developers are partnering with medical institutes to offer integrated clinical health services as standard residential amenities. For instance, premium clinics like Atria Health are opening integrated facilities right inside high-end residential towers from Manhattan's Billionaires' Row to Beverly Hills.
Hyper-Personalized Travel: High-end hospitality brands are transforming into preventative labs. In curated "Longevity Travel" ecosystems, traditional welcome drinks are swapped for comprehensive biomarker blood draws upon arrival. These results instantly shape tailored, medical-grade recovery protocols for the duration of the guest's stay.
Subscription Clinics & Clubs: The luxury sector is leveraging exclusive membership models to provide ongoing, continuous data tracking, cellular therapies, and physician-led lifestyle design.
Cognitive Optimization: Luxury is expanding deeply into brain health. Elite clinics, such as the SHA Wellness Clinic, blend neuroscience, advanced brain mapping, and specialized infusions to optimize memory, mental clarity, and stress resilience.

Core Pillars of Living Younger

While ultra-wealthy early adopters fund high-end therapies like full-body MRIs, peptide injections, and stem-cell treatments, the fundamental pillars of lowering your biological age rely on accessible, systemic lifestyle principles.

Pillar	Focus Area	Actionable Goal
Advanced Diagnostics	Biomarker Tracking	Regular analysis of blood panels, biological markers, and functional fitness tracking.
Metabolic Health	Cellular Vitality	Incorporating scientific supplementation and targeted nutrition to optimize energy and combat cellular aging.
Physical Optimization	Strength & Movement	Daily low-friction exercise, post-meal walking, and structured strength training.
Neurological Recovery	Sleep Architecture	Utilizing specialized environments and schedules to prioritize restorative deep sleep and limit stress.
Social Architecture	Community Connection	Cultivating high-quality social interactions and multi-generational family bonds.

The Democratization Challenge

A growing socio-economic question defines this era: Is longevity a basic human necessity or an exclusive luxury commodity? The premium market functions as a critical funding mechanism. High-net-worth early adopters absorb the initial high costs of emerging biotech and diagnostic technologies. Over time, scale, automation, and institutional integration compress these costs, gradually introducing these life-extending protocols to the broader public.

Finally, My Reel of the Day:

https://www.facebook.com/reel/1728880988102741

Highlights of My Professional Career

In my more than 40 years of professional career, I have experienced both working rank and file, as well as supervising the work of subordinates. I have worked in four private firms and the Federal Government, the Food and Drug Administration (FDA), where I retired. I enjoyed the challenges and difficulties of both types of job situations. This is the highlights of my work experience story.

My first job after completing my doctorate degree was a Chemist for Chemagro Corporation in Kansas City, Missouri. It was a subsidiary of Bayer Corporation, a German conglomerate. I worked for the analytical chemistry department comprised of about fifty people; half that number was either chemists or biologists. My specific task was to develop analytical methods for the detection of pesticide residues in plant and animal tissues. I worked on my own, similar to six other bench chemists, and we all reported to the same supervisor.

The firm sponsored my visa conversion from a student to a permanent resident, and I was able to legally work and reside in the United States with my family. The company generously took care of its employees. At the end of each successful year, everyone received a 13th month salary bonus. The employees and their families celebrated wonderful annual Christmas parties in a downtown Kansas City hotel, with dancing and free drinks for the whole night.

Inasmuch as I enjoyed and loved working for Chemagro for five years, I found a new job which offered a substantially higher pay. Due to my exemplary work performance, my supervisor preferred and lobbied for me to stay with the company. I had to turn him down because they could not match the package presented by my new employer. It was also a chance for me and my family to move and live in the US west coast, where the mild winter climate is bearable compared to the Midwest.

My next job was at the agricultural research division of Shell Development Company in Modesto, California. I was a Research Chemist, and again I worked individually, same as five other chemists who all reported to a supervisor. My specific duty was similar to my previous job. I worked for them for five years, until the company decided to get out of the pesticide business. They closed their research facility affecting the jobs of more than 200 employees.

My third industrial job was with the agricultural research division of Stauffer chemical company, located in Richmond, California. I was a Senior Research Chemist doing the same project as my two previous jobs. I worked for twelve continuous years for the company, with outstanding annual job performance. I became a Principal Research Chemist, the highest attainable non-supervisory position.

One day in 1986, my supervisor informed me that my job had been eliminated, and I had one day to vacate the facility. It was the most dreadful lay off experience in my life. I felt anger, sadness and humiliation to be dismissed from work with one day notice, after all the years of hard work invested for the company. This was an unforgettable incident and was the gloomiest point in my professional career.
The company terminated sixty research employees, who were upset of the bad news.

One of the chemists was distressed and expressed his outrageous anger by threatening the company and its workers. He told his supervisor of his intention to bomb and burn down the laboratory. He was immediately escorted by the security staff out of the building and into his car. He was informed to leave behind his personal belongings; they will be mailed to his residence. He was warned never to show up again near the company premises or risk getting arrested.

My supervisor was kind and allowed me to take my time to pack up my belongings. It took me two days to clear up my workplace, after toiling for a long period in the same jobsite. We were provided clerical help and office space, in preparation to look for another job, such as updating our resumes, and using the computer and copy machine. We were given six weeks of separation pay plus benefits.

Fortunately, with the help of a friend who is a Church parishioner, I found another job thirty days after leaving Stauffer chemical company. He hired me as a senior research chemist and as a group leader with two technicians to supervise. It was in the same field as my expertise in my previous three jobs spanning the last twenty one years. My new employer was Chevron Chemical Company, and which was located in the same area as my former employer.

This job gave me the introduction and basic knowledge of managing the work of subordinates. I worked for Chevron Company for four and a half years. The company decided to consolidate their research facilities in Texas, and lay off all its research employees. This time I had enough distress and agony from working, and eventually getting laid off from several private companies. To avoid going through any more miserable layoffs, I made a vow that I would never again work for a private company.

In my work experiences, there were noticeable and unavoidable jobsite occurrences. One can never miss the office romantic relationships between co-workers, both illicit and permitted. Though it was frowned upon, there was a boss and staff relationship, which was used as a ploy to get ahead in the company. Some relationships had chemistry, no pun intended, but some never worked out. Oftentimes, there was a sense of distrust among bench chemists for some workers who unjustly obtained preferred work assignments.

Some employees resorted to bribing superiors to get special privileges, such as being able to attend choice conferences and meetings in exciting venues or locations. Likewise, politics was always present at the worksites. It was during an era when various forms of harassment, equal opportunity and discrimination laws were not yet enforced in the workplace. Occasionally, an unexpected chemical explosion happens in a laboratory setting, where luckily no one got seriously hurt.

In the three private companies I worked for, I was able to publish scientific journals for some of the research studies and analytical methods which I developed for the respective companies of Chemagro, Shell Development and Stauffer.

After deciding and making a vow to avoid working in the private sector, I made my new goal which was either to work for the state of California, or the Federal government in Washington, D.C. Four months after I lost my job in Chevron, I was lucky and joyful to be hired by the Food and Drug Administration as a review chemist in the fall of 1990.

In 1994 I was promoted as an Expert Research Chemist with a GS-14 rating. My expertise was on Anti-malarial and Anti-parasitic drug products. In 1997, I was again deservingly promoted to Chemistry team leader, supervising the work of six Chemistry reviewers including five with doctorate degrees.

As team leader, I was responsible for prioritizing, assigning, and assuring the technical accuracy of all chemistry, manufacturing and control issues for all new drug applications submitted to the Division of Anti-Infective Drug Products, Center of New Drugs.

It was part of my responsibility to give advice, instruct and promote high morale and teamwork in my group. My work in the FDA is confidential, until the drug patent on the products I worked on has expired. There are manufacturing supplements that I have approved that are now open for the public in the Internet.

In 1998, I won the Equal Employment Opportunity (EEO) Award. The citation reads, “For outstanding accomplishments in fostering the objectives of the EEO Program by hiring minorities and encouraging their professional growth while providing excellent leadership.” I have received numerous certificates of appreciation, awards in leadership and communications, commendation for teamwork and excellence in the accomplishment of the FDA mission. I have also received several letters of appreciation from private industry for my review work.

There are many good things working as rank and file while enjoying doing one’s job individually. It is a humbling, satisfying and productive experience, if one can work in harmony with one’s immediate supervisor. Working individually develops one’s skills in goal setting and scheduling. But in general, the financial rewards are less than a person who has supervisory responsibilities.

Managing the work of others has its challenges. Moreover, it develops one’s skill in handling and developing people, and the compensation rewards and benefits are better. Due to additional duties, responsibilities and leadership, supervisory work can be more stressful than working as a subordinate. However, supervisory jobs give one more personal growth and satisfaction, based on my personal experience. My work in FDA as a team leader managing the work of six scientists had been the happiest and rewarding work experience in my career in Chemistry. You might also like: